NeuroSense Therapeutics NRSN
NASDAQ NRSN
$2.58 +0.19 (+7.88%)
As of: Oct 21, 2026 · 2:23 PM EDT

NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024)

Updated

NeuroSense Therapeutics' EPS (Basic) was -$8.73 in FY2025, compared with -$10.98 in FY2024.

Analysis

NeuroSense Therapeutics (NRSN) EPS (Basic) (2021 - 2024) Analysis & Trends

From FY2020 onward, NeuroSense Therapeutics has reported EPS (Basic) for 6 years.

  • The FY2025 figure marks the highest annual EPS (Basic) in data going back to FY2020.
  • Per Business Quant data, EPS (Basic) in earlier years was -$10.98 in FY2024, -$16.23 in FY2023, -$20.25 in FY2022 and -$13.31 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 7.95
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn 2.30
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn 2.04
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn -0.54
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn 1.68
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 1.62
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 4.40
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn -8.44
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -0.04
10 NeuroSense Therapeutics 3.28 Mn -1.16 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.94
Sep 30, 2024 -3.15
Jun 30, 2024 -1.26
Mar 31, 2024 -7.92
Dec 31, 2023 -4.67
Sep 30, 2023 -0.61
Jun 30, 2023 -6.34
Mar 31, 2023 -5.08
Dec 31, 2022 -2.26
Sep 30, 2022 -9.59
Jun 30, 2022 -11.15
Mar 31, 2022 -8.70
Dec 31, 2021 2.31
API Access

NeuroSense Therapeutics EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=NRSN&period=max&api_key=YOUR_API_KEY